When it comes to
Bangladesh, one would always find the country enlisted among the developing
countries in terms of economy. Deemed to be the 44th largest economy of the
world, the pharmaceutical industry of the country has quite a significant
contribution in the picture. And if one had to talk about the leading
pharmaceutical export brand of the nation, then the Beximco Pharmaceutical
Limited, with UNICEF and WHO, ADF and Save the Children to its credit
definitely makes it to the list.
Beximco Pharmaceuticals
easily occupies one of the top positions when it comes to the production and
export of pharmaceutical formulations and Active Pharmaceutical Ingredients in
Bangladesh. Recognized globally, the operation of this company extends to
Australia, Gulf nations, European Union, Brazil and many other parts of the
globe. Currently manufacturing over 500 different medical products, including
therapeutic ones, such as, antihypertensives, antiretrovirals, antibiotics,
antidiabetics, anti asthma inhalers and the like, the Beximco Group mirrors the
effects of skilled manpower with consistent dedication in the field and
formulation capabilities. And what’s more, the company offers generic drugs,
high up in the quality scale at absolutely affordable prices all across the
globe.
The
Picture of Pharmaceutical Export in Bangladesh and Beximco Pharmaceutical
Limited
Deemed to be one of the
most progressive industries of Bangladesh, the pharmaceutical industry is one
of the most significant contributors to the country’s economic picture. The
industry accounts for a domestic market of US $1.136 billion, with a growth
rate that touched 23.59% in the year 2011. Taking the entire thing into
account, it is not surprising that the industry has quite a share as far as
contribution to the GDP is concerned. With an aim to export generic medical
products worth US $5 billion, it is not surprising that the Beximco Group is
all geared up in the direction.
The only pharmaceutical
organization to receive the National Export Trophy (Gold) in Bangladesh for
record four times, the Beximco Pharmaceutical Limited has a global reach in
more than 45 nations all across the globe. With its sight now set on the
emerging markets of CIS, the organization is now increasing its focus on the
regulated markets of USA and EU. Apart from this, the medical products of the
company are also being supplied to hospitals and institutions, such as,
Kenyatta National Hospital in Kenya, Jinnah and Agha Khan Hospital in Pakistan,
KK Women and Children Hospital in Singapore and the like.
Due to an initiative
taken by the World Trade Organization, pharmaceutical companies of Bangladesh
have managed to gain quite a foothold in the global picture and the BeximcoGroup is no exception. As per the regulations, the company, along with others
will be able to export patented products up to December 2015. Accordingly, the
export figure of the Beximco Group is expected to multiply manifold, with the
company expanding its range to incorporate parental dosage of ophthalmology and
nebulizer. The company has also gained the approval of the Therapeutic Goods Administration (TGA)
of Australia and AGES
of Austria (European Union) in this regard.
